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The LIM homeodomain transcription factor, LHX3, is essential for pituitary development in mouse and man. Lhx3 engineered null mice have
profound pituitary hypoplasia that we find is attributable to an increase in cell death early in pituitary development. Dying cells are localized to
regions of TPIT expression indicating that cell death may contribute to the severe reduction in differentiated corticotrope cells and lower
expression of the corticotrope transcription factors, TPIT and NEUROD1. Lhx3 deficiency also results in dorsal ectopic expression of transcription
factors characteristic of gonadotropes, SF1 and ISL1, but no gonadotropin expression. This apparent disturbance of cell differentiation may be
due, in part, to loss of NOTCH2. NOTCH2 is normally expressed in the pituitary at the boundary between dorsal, proliferating cells and ventral,
differentiating cells and is important for maintaining dorsal–ventral patterning in other organs. Thus, Lhx3 contributes significantly to pituitary
development by maintaining normal dorsal–ventral patterning, cell survival, and normal expression of corticotrope-specific transcription factors,
which are necessary for repressing ectopic gonadotrope differentiation.
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The pituitary gland secretes hormones that regulate growth,
metabolism, reproduction, lactation, and stress response (Cush-
man and Camper, 2001). Pituitary organogenesis begins in mice
at embryonic day 8.5 (e8.5). Signaling molecules such as bone
morphogenetic proteins (BMPs), fibroblast growth factors
(FGFs), and sonic hedgehog (SHH) are involved in initiating
pituitary development (Savage et al., 2003; Scully and
Rosenfeld, 2002). A portion of the oral ectoderm invaginates
to form a rudimentary pouch structure known as Rathke's pouch
that ultimately develops into the anterior and intermediate lobes
of the adult pituitary (Schwind, 1928).
Synthesis and secretion of pituitary hormones are regulated
by hypothalamic input and feedback from target organs. The
anterior lobe contains five specialized hormone-secreting cell
types. Somatotropes produce growth hormone (GH) that targets⁎ Corresponding author. Fax: +1 734 763 5831.
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doi:10.1016/j.ydbio.2007.10.006the liver and bone. Lactotropes secrete prolactin (PRL) that acts
on the mammary glands. Gonadotropes produce follicle-
stimulating hormone (FSH) and luteinizing hormone (LH)
that regulate function of the gonads. Thyrotropes secrete
thryroid-stimulating hormone (TSH) that targets the thyroid.
Finally, corticotropes produce adrenocorticotropic hormone
(ACTH) that acts on the adrenal gland.
Normal pituitary development and function depends on
specific expression patterns of transcription factors (Scully and
Rosenfeld, 2002). LHX3, also known as LIM-3, pituitary LIM
or P-LIM, is one of these essential transcription factors. It is a
member of the LIM homeodomain (LIM-HD) subfamily,
named after the first three factors discovered in the family
(LIN-11, Isl-1, and MEC-3) (Cohen and Radovick, 2002).
Several genes in this family are expressed in the developing
pituitary including Isl1, Lhx2, and Lhx4 (Roberson et al., 1994;
Sheng et al., 1997; Thor et al., 1991). LHX3 expression is first
observed throughout Rathke's pouch in the developing mouse
pituitary at e9.5 (Sheng et al., 1996). It is expressed in a gradient
at e12.5 with higher protein levels found in the dorsal aspect of
Rathke's pouch (Raetzman et al., 2002). Expression persists
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gland, LHX3 is expressed in the hindbrain, pineal gland, and
spinal cord where it triggers differentiation of V2 spinal motor
neurons by binding the LIM cofactor NLI (Glasgow et al., 1997;
Thaler et al., 2002).
Lhx3 null mice lack the exons encoding two LIM domains
and some of the homeodomain, which results in no detectable
mRNA (Sheng et al., 1996). Heterozygous mice appear normal,
but homozygous mutant mice do not survive past birth, and the
exact cause of death is unknown. LHX3 null mice have normal
pituitary induction and formation of a rudimentary Rathke's
pouch, but after embryonic day e9.5 the mutant phenotype
becomes evident. Mutants have a more thinly walled pouch
compared to wild type embryos, and they retain a narrow cellular
connection to the oral ectoderm. Later in gestation, Rathke's
pouch remains rudimentary and undifferentiated; however, the
posterior lobe is present and appears grossly normal.
Lhx3 null embryos fail to express Pit1 (Sheng et al., 1996),
which is critical for the development of the thyrotrope,
somatotrope, and lactotrope cell types (Li et al., 1990). Fully
differentiated gonadotropes are not detectable and there are
fewer corticotropes than normal. The underlying mechanisms
for the loss and reduction of cell types is not known (Sheng et
al., 1996). Thus, Lhx3 is required for complete differentiation of
four of the five anterior pituitary cell types and for establishing a
normal cohort of corticotropes by birth.
LHX3 mutations have been described in human subjects.
Most affected patients exhibit restriction of neck rotation and
serum deficits of all anterior pituitary hormones except ACTH
(Pfaeffle et al., 2007). Additionally, three patients had severe
anterior pituitary hypoplasia (Bhangoo et al., 2006; Netchine et
al., 2000). These clinical features are consistent with the
phenotype of the mouse model (Sheng et al., 1996), with the
exception that Lhx3 null mice die as neonates and human LHX3
null patients survive into adulthood.
In the last 10 years, many transcription factors with roles in
human disease and mouse pituitary development have been
identified. An important challenge is to determine how
expression of each of these factors affects expression of other
genes involved in pituitary development. When the Lhx3 null
mice were originally characterized, very few critical pituitary
transcription factors had been identified. We report an in-depth
analysis of the effect of Lhx3 inactivation on the many factors
that have been identified since the initial studies. This work
reveals a previously unappreciated role of Lhx3 in dorsal–
ventral patterning. In addition, multiple lines of evidence from
this study support a non-linear process of differentiation for
pituitary hormone producing cells.
Materials and methods
Mice
Heterozygous Lhx3 engineered null mice were obtained from Dr. H.
Westphal (Laboratory of Mammalian Genes and Development, National
Institute of Child Health and Human Development, National Institutes of
Health, Bethesda, MD) on a mixed background containing C57BL6/J. The stock
was expanded at the University of Michigan by crossing to C57BL6/J. Timedpregnancies were generated through heterozygote matings, and the morning
after mating was designated as embryonic day 0.5 (e0.5). All mice were given
unlimited access to tap water and Purina 5020 chow. Mice were housed in a 12-h
light, 12-h dark cycle. All procedures using mice met the approval of the
University of Michigan Committee on Use and Care of Animals. Also, all
experiments were conducted in accordance with the principles and procedures
outlined in the NIH Guidelines for the Care and Use of Experimental Animals.
PCR genotyping
Embryonic genotypes were determined using specific primers for the wild
type allele (sense primer 5′-CGGTGGCGACGGCTTTTGTA- 3′ and antisense
primer 5′-GCACCCAGGGCCCACTCACT- 3′) to yield a 386-bp product. The
neomycin gene present in the targeted allele was amplified using (sense primer
5′-CTGTGCTCGACGTTGTCACTG-3′ and antisense primer 5′-GATCCCCT-
CAGAAGAACTCGT-3′) to produce a 566-bp band.
Immunohistochemistry
Embryos were fixed in 4% paraformaldehyde in phosphate buffered saline
(PBS, pH 7.2) on ice. Embryos at day 10.5, 11.5, 12.5, 14.5, and 18.5 were fixed
for 1.5, 2, 2, 2.5 h, and overnight, respectively. All samples were washed in PBS
and dehydrated through successively more concentrated ethanol solutions and
embedded in paraffin. Tissue sections of 6 μm thickness were prepared for
fluorescent immunohistochemistry.
Slides were deparaffinized, rehydrated, and washed once in PBS before
staining. Endogenous peroxidases were quenched by incubation in 1.5%
peroxide in methanol for 20 min. Epitopes were exposed by boiling in 10 mM
citric acid (pH 6.0) for 10 min. The TSA (tyramide signal amplification)-
fluorescein isothiocyanate (FITC) (Perkin-Elmer Life Sciences, Boston, MA)
was used as per manufacturer directions for immunohistochemistry with the
rabbit anti-PITX1 antibody (1:1500; J. Drouin, Institut de Recherches Cliniques
de Montreal, Montreal, Quebec, Canada). Slides were incubated overnight at
4 °C, incubated with biotinylated anti-rabbit secondary antibody (1:200; Jackson
Immunoresearch Laboratories, West Grove, PA) for 30 min. Following a 5 min
incubation with water, sections were counterstained with 4′,6-diamidino-2-
phenylindole (DAPI) (167 nM, Molecular Probes). All stains using primary
antibodies from rabbit were carried out using the above protocol. These
antibodies include: SF1 (1:1500; K. Morohashi, National Institute for Basic
Biology, Myodaiji-cho, Okazaki, Japan); TLE3 (GRG3) (1:600; Chemicon
International, Inc., Temecula, CA); PITX2 (1:250; J. Drouin, Institut de
Recherches Cliniques de Montreal, Montreal, Quebec, Canada); NEUROD1
(1:10; J. Drouin, Institut de Recherches Cliniques de Montreal, Montreal,
Quebec, Canada); TPIT (1:200; J. Drouin, Institut de Recherches Cliniques de
Montreal, Montreal, Quebec, Canada); PC2 (1:100; Chemicon International,
Inc., Temecula, CA).
Immunohistochemistry with the mouse anti-ISL1 (1:1200; Developmental
Studies Hybridoma Bank, Univ. of Iowa) and mouse anti-NOTCH2 (1:1500;
Developmental Studies Hybridoma Bank, Univ. of Iowa) was carried out using
the Mouse on Mouse (MOM) kit (Vector Laboratories, Burlingame, CA)
according to the manufacturer's directions.
For co-staining experiments, slides were incubated with CASPASE3, SF1,
ISL1, or TLE3 primary antibodies and then with the appropriate secondary
antibodies as previously described. The CASPASE3, SF1, and TLE3 slides were
blocked with anti-rabbit Fab' (1:100; Jackson Immunoresearch Laboratories),
and ISL1 slides were blocked with anti-mouse antibodies from the MOM kit
(Vector Laboratories, Burlingame, CA). Slides were then incubated with rabbit
anti-PITX1 (1:1500; J. Drouin, Institut de Recherches Cliniques de Montreal,
Montreal, Quebec, Canada) or POMC overnight at 4 °C followed by incubation
with TRITC or FITC-conjugated anti-rabbit antibodies (1:200; Jackson
ImmunoResearch Laboratories,West Grove, PA) for 30min at room temperature.
Digital images of pituitary sections were captured with a Leitz DMRB
microscope (W. Nuhsbaum, Inc., McHentry, IL) and an Optronics camera
(Goleta, CA). FITC and DAPI section pictures were merged using Adobe
Photoshop 7.0.
To detect cell proliferation in embryonic pituitaries, pregnant mice were
given an intraperitoneal injection of bromodeoxyuridine (BrdU) at 100 μg/g
body weight 2 h before the embryos were harvested (Nowakowski et al., 1989).
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Immunologicals Direct) and detected with a TRITC-conjugated secondary
antibody (1:200; Jackson ImmunoResearch Laboratories, West Grove, PA).
Programmed cell death in the pituitaries was also detected by the TUNEL
method using the in situ cell detection kit POD (Roche, Indianapolis, IN).Results
Cell death is increased in Lhx3 null pituitaries
To explore the mechanism underlying the hypoplastic
pituitary phenotypes of Lhx3 mutant homozygotes, we
compared cell proliferation and cell death in Lhx3 null embryos
with their wild type littermates. We detected proliferation in
Lhx3 null embryos by intraperitoneal injections of bromodeox-Fig. 1. Pituitary hypoplasia is due to increased apoptosis in Lhx3 mutant mice. (A–D
rhodamine (red). Rathke's pouch is stained with PITX1 antibody and labeled with
different by e11.5; however, no obvious difference in proliferative signal is appar
immunohistochemistry performed with an antibody directed against activated C
Immunohistochemistry with PITX1 antibody was used to highlight Rathke's pouch an
and e12.5, which are labeled with fluorescein (green). Cell nuclei are labeled with Dyuridine (BrdU) into pregnant females. BrdU, a thymidine
analog, is incorporated into newly synthesized DNA strands
during the S-phase of the cell cycle. Even though the
morphology of pituitaries from null animals is significantly
different from normal, no difference in the fraction or pattern of
proliferating cells was obvious between normal and mutant
mice at e11.5, e12.5 (Fig. 1), or e14.5, data not shown. We
stained for activated CASPASE3, an indicator of apoptosis, and
verified the presence of apoptotic cells by TUNEL (Terminal
deoxynucleotidyl Transferase Biotin-dUTP Nick End Labeling)
assay for DNA degradation. In normal pituitary organogenesis,
cell death appears to play a transitory role in the separation of
Rathke's pouch from the rest of the oral ectoderm at e10.5 and
e11.5 (Charles et al., 2005). Dying cells are normally only
located at the ventral region of the invaginated oral ectoderm) BrdU incorporation is detected with immunohistochemistry and labeled with
fluorescein (green). The morphology of Lhx3 mutant pituitaries is noticeably
ent between normal and mutant pituitaries. (E–H) Apoptosis was detected by
ASPASE3 and development with fluorescein (green) at e11.5 and e12.5.
d developed with rhodamine (red). (I–L) TUNEL detects apoptotic cells at e11.5
API (blue).
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significant increase in apoptotic cells in the ventral portion of
Rathke's pouch in Lhx3 null embryos at e11.5, e12.5, and e14.5
(Fig. 1 and data not shown). At e11.5, apoptosis is prevalent
along the epithelial connection between the oral cavity and
pouch and also in the ventral portion of the mutant Rathke's
pouch. At e12.5, apoptosis is detected in the ventral portion of
Rathke's pouch with both TUNEL and CASPASE3 staining.
These observations cannot be explained by developmental
delay because normal pituitary primordia have fewer apoptotic
cells at earlier times (Charles et al., 2005). Thus, an increase in
apoptosis is a major contributor to the hypoplasia in Lhx3 null
pituitaries.
Fewer differentiated melanotropes and corticotropes are
evident in Lhx3 null pituitaries
Consistent with the observations of Sheng et al. (1996), we
found that the number of cells producing POMC is severely
reduced at e14.5 and e16.5 such that very few or no
immunoreactive cells are detectable on an individual section
(Figs. 2A, B, E, F). This indicates that differentiation of both
corticotrope and melanotrope cells is impaired. The Groucho-
like co-repressor, TLE3 (transducin-like enhancer of split 3), is
normally expressed strongly in the prospective intermediate
lobe with some scattered expression in the anterior lobe and
periluminal area (Brinkmeier et al., 2003). We demonstrate that
at e16.5 the majority of TLE3 positive cells, which are
identified as green nuclear staining, also express POMC,
which appears as red cytoplasmic staining (Fig. 2E, inset).
Interestingly, TLE3 exhibits grossly normal expression in Lhx3
mutants at e14.5 and e16.5 (Figs. 2C–F). In spite of this,
expression of POMC is severely reduced in the mutant at e16.5
(Figs. 2E, F). Likewise, expression of the melanotrope marker,
prohormone convertase 2 (PC2), is nearly undetectable in the
mutant at e18.5 (Figs. 2G, H). Together, these data demonstrate
that while there are a number of cells present in the mutant
prospective intermediate lobe that are capable of expressing
TLE3, very few melanotrope cells complete differentiation.
Apoptosis results in a reduction in the number of corticotrope
cells in Lhx3 null pituitaries
To determine why only a few corticotrope cells fully
differentiate in the Lhx3 mutant, we used immunohistochem-
istry to compare spatial and temporal expression patterns of
NEUROD1 and TPIT (TBX19). These proteins work in synergy
with PITX1 to activate transcription of the Pomc gene and
promote differentiation of the corticotrope and melanotrope
lineages (Lamolet et al., 2001, 2004; Poulin et al., 1997;
Pulichino et al., 2004; Reynaud et al., 2004). Our results show
that Lhx3 null pituitaries express TPIT at e12.5, but instead of
exhibiting greatly expanded expression at e14.5 like wild type
mice, there are fewer positive cells than at e12.5, and no
detectable protein at e18.5 (Figs. 3A–F). NEUROD1 expres-
sion is not detectable in Lhx3 null mutants at e12.5 and barely
detectable at e14.5 (Figs. 3G–J). Thus, Lhx3 is necessary, eitherdirectly or indirectly, for robust expression of both Neurod1 and
Tpit.
Interestingly, at e12.5, the nuclei of TPIT positive cells in
mutant pituitaries have a fragmented appearance, making it
tempting to postulate that these cells are dying (Fig. 3B). We
labeled serial sections from e12.5 wild type and Lhx3-deficient
pituitaries with TPIT and CASPASE3 and determined that
immunoreactivity for both proteins is detected in the same
locations of Lhx3 null pituitaries (Figs. 3K, L). It is likely,
therefore, that a portion of the dying cells are corticotropes.
Thus, cell death early in pituitary development may contribute
to the lack of corticotrope cells that is characteristic of Lhx3
mutants, as well as reduced expression of TPIT and NEUROD1.
Pre-gonadotrope cells appear dorsally late in pituitary
development
Steroidogenic factor 1 (SF1 or NR5A1)-deficient humans
and mice have little or no LH and FSH (Ikeda et al., 1995; Lin et
al., 2007). SF1 is first expressed in the ventral aspect of the
anterior lobe at e14.0 in wild type mice and continues to be
detectable through adulthood in the ventral region of the
anterior lobe where gonadotropin expression typically emerges
several days later. SF1 is not normally expressed in any other
area of the pituitary gland. In Lhx3 null mice, a few SF1 positive
cells are present in the ventral portion of Rathke's pouch at
e14.5 as expected (Figs. 4A, B). However, an additional site of
SF1 expression appears in the dorsal aspect of the pituitary by
e18.5 in the mutants (Figs. 4C, D). The absence of detectable
LHβ (Figs. 4E, F) indicates that these cells are unable to com-
plete a gonadotrope differentiation program despite their ex-
pression of SF1.
Isl1 is a LIM factor that is necessary for expansion of
Rathke's pouch and for normal transcription of the GnRH
receptor gene in gonadotropes (Granger et al., 2006). We
investigated Isl1 expression in Lhx3 mutant pituitaries and
found an on-off- and then on again pattern of ISL1 expression
instead of the steady expression of this factor observed in wild
type pituitaries. ISL1 is expressed normally at e9.5 in the
invaginating oral ectoderm of Lhx3 null mice but is undetect-
able at e12.5 (Figs. 4G–J). At e16.5 and e18.5, ISL1 is
expressed ectopically in the dorsal aspect of the pituitary as
observed for SF1 (Figs. 4K, L, and data not shown). ISL1 is also
expressed at e10.5 and e14.5 in Lhx3 mutants (data not shown).
Thus, Lhx3 appears to be required for maintaining expression of
Isl1 at e12.5 and for restricting its expression ventrally later in
development.
Loss of NOTCH2 may contribute to abnormal dorsal–ventral
patterning
Pituitary growth and differentiation are dependent on the
combined dosage of PITX1 and PITX2 transcription factors,
with PITX2 having a more prominent role than PITX1 (Charles
et al., 2005; Lanctot et al., 1999; Szeto et al., 1999). PITX2 is
necessary for development of Rathke's pouch and later for
promoting expression of transcription factors necessary for
Fig. 2. The majority of cells in the intermediate lobe fail to differentiate into hormone producing cells. Immunohistochemistry was performed on mid-sagittal paraffin
sections from Lhx3 mutant embryos and wild type littermates with antibodies directed against (A, B, E, F) POMC and (C–F) TLE3, shown in green and red as
indicated and (G, H) PC2, developed with DAB and shown in (brown). The inset (E) shows that the majority of TLE3 positive cells (green nuclear staining) also
express POMC (red cytoplasmic staining). (A–F) Cell nuclei are stained with DAPI (blue). The intermediate lobe is identified with white brackets and mutant
pituitaries are outlined with dotted lines.
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proposed to be more important for differentiation of ventral cell
types than dorsal ones (Lanctot et al., 1999; Suh et al., 2002).
PITX1 and PITX2 are expressed throughout pituitary organo-
genesis, and at e18.5 PITX1,2 expressing cells are enriched in
the ventral aspect of the gland. Both genes are expressed in
Lhx3 null mice. However, PITX1,2 expressing cells appear tobe enriched dorsally rather than ventrally at e18.5 (Figs. 5A–D,
data not shown). The reduced ventral expression of these genes
could contribute to the failure of ventral cell types to
differentiate.
NOTCH signaling has been shown to be important for
forming dorsal–ventral boundaries during organ formation
(Micchelli and Blair, 1999; Mucchielli and Mitsiadis, 2000). In
Fig. 3. Deficiency of corticotropes corresponds to reduced expression of TPIT and NEUROD1 in Lhx3 mutant pituitaries. (A–F) TPIT and (G–J) NEUROD1 are
detected in pituitaries from wild type and Lhx3 engineered null mice with immunohistochemistry and labeled with fluorescein (green). (A–J) Cell nuclei are stained
with DAPI (blue). The anterior lobe is identified with white brackets and null pituitaries are outlined with dotted lines. TPIT and NEUROD1 are almost completely
absent in Lhx3 null pituitaries. A few TPIT and NEUROD1 immunoreactive cells can be detected in Lhx3 null pituitaries (arrowheads, D and J). Serial, midsagittal
sections from e12.5 pituitaries were stained by immunohistochemistry for (K) TPIT (green) or (L) activated CASPASE3 (red). Immunoreactivity of TPIT and
CASPASE3 is seen in approximately the same regions as indicated by arrows.
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in Rathke's pouch in an area between the highly proliferating
cells in the dorsal aspect of the pouch and the differentiating
cells located more ventrally (Raetzman et al., 2004). NOTCH2
is undetectable in Lhx3 null pituitaries at e12.5 (Figs. 5E, F).
Discussion
Loss of Lhx3 leads to a unique pattern of increased cell death
Pituitary hypoplasia can result from increased apoptosis,
decreased proliferation, or both. Several single gene knockout
mice with adult pituitary hypoplasia exhibit apoptosis early in
development that occurs throughout Rathke's pouch. These
include Fgf10 (Ohuchi et al., 2000), Fgfr2 (De Moerlooze etal., 2000), and Lhx4 (Raetzman et al., 2002). In some mutants
with pituitary hypoplasia, the apoptosis is more regionally
confined. For example, Pitx2 null mice have cell death
extending almost to the most dorsal tip of Rathke's pouch at
e11.5, which leads to a small pituitary primordium (Charles et
al., 2005). Prop1 mutants do not develop hypoplasia until after
birth, and undifferentiated cells die in the first two weeks after
birth in a highly scattered pattern (Ward et al., 2005). Finally,
Pit1 mutants have normal sized pituitaries at birth and exhibit
very little apoptosis at any stage, but undergo reduced cell
proliferation after birth leading to hypoplastic adult pituitaries
(Ward et al., 2006). These examples illustrate how individual
genetic defects can cause different spatial and/or temporal
patterns of apoptosis, decreased proliferation, or both, leading to
hypoplasia. We saw no obvious change in the fraction or pattern
Fig. 4. ISL1 and SF1 are expressed ectopically in the dorsal region of Lhx3 mutant pituitaries. SF1 (A–D), LHβ (E, F), and ISL1 (G–L) were detected by
immunohistochemistry and labeled with fluorescein (green). Cell nuclei are labeled with DAPI (blue). SF1 and ISL1 are expressed in some ventral cells as expected;
however, they also exhibit ectopic expression at e18.5 in the dorsal aspect of Lhx3 null pituitaries (arrowheads; D and L). ISL1 expression is lost transiently at e12.5.
Consistent with the findings of Sheng et al. (1996), LHβ is not detected in the mutant pituitary at e18.5 (E, F) or e16.5 (data not shown). (A–L) The anterior lobe is
identified with white brackets and null pituitaries are outlined with dotted lines.
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apoptosis in the ventral aspect of the Lhx3 null pituitary. This
confirms and extends a report of increased cell death in a dif-
ferent Lhx3-deficient mouse model containing a Cre insertion
in the Lhx3 locus that produces an unstable transcript (Zhao et
al., 2006). Together, these data indicate that apoptosis is a major
contributor to the hypoplasia associated with Lhx3 deficiency.
Lhx3 is required for melanotrope differentiation
In rodents, cells that express pro-opiomelanocortin (POMC),
adopt different fates (Japon et al., 1994). Corticotropes appear
at e12.5 in the prospective anterior lobe and POMC is cleaved
into adrenocorticotropic hormone (ACTH) by prohormone con-
vertase 1 (PC1). Several days later at e15.5, POMC is detectable
in melanotropes in the intermediate lobe where it is processedinto α melanocyte stimulating hormone (αMSH) using pro-
hormone convertases 1 and 2 (PC1, PC2) (Marcinkiewicz et al.,
1993).
Tpit is required for POMC expression in the intermediate and
anterior lobes (Lamolet et al., 2001). The basis for differentiated
expression of PC2 is unknown. The Groucho/TLE transcription
factor, TLE3, is expressed in the developing intermediate lobe
at e12.5–e16.5 in a pattern that primarily overlaps with POMC
and αMSH (Brinkmeier et al., 2003). Most TLE3 expressing
cells in the intermediate lobe also express POMC. The role of
Tle3 in pituitary gland development is unknown, but its
temporal and spatial expression pattern suggest that it could
play a role in maintenance of cell proliferation and/or
intermediate lobe cell fate specification. Members of the
Groucho/TLE family are important for cell fate specification
in the eye, spinal cord, and other organs (Doyle et al., 2007; Lee
Fig. 5. Strong dorsal expression of PITX1 is seen in the absence of NOTCH2. PITX1 is detected in wild type and Lhx3 null mouse pituitaries at e12.5 and e18.5 by
immunohistochemistry and labeled with fluorescein (green) (A, B) or rhodamine (red) (C, D). PITX1 is expressed normally at e12.5; however, at e18.5 its expression
pattern appears to be reversed, with stronger expression in the dorsal aspect of the mutant gland instead of the more prominent ventral expression characteristic of wild
type mice. (E, F) NOTCH2 (green) is detected on the surface of periluminal cells in wild type pituitaries between the dorsal and ventral aspects. Absence of NOTCH2
in Lhx3 null pituitaries may contribute to the dorsalization of ventral cell markers. Cell nuclei are labeled with DAPI (blue). (A–F) The anterior lobe is identified with
white brackets and mutant pituitaries are outlined with dotted lines.
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et al., 1998).
We observed a failure of the intermediate lobe to produce
PC2 in the absence of Lhx3. This is unlikely to involve Tle3,
however, as expression of TLE3 is largely normal in the
mutants. TPIT is strongly expressed in the intermediate lobe of
wild type mice in late gestation but absent in the prospective
intermediate lobe of Lhx3 mutants. Thus, the failure of
melanotrope cells to express POMC is probably caused by
lack of TPIT expression. This is consistent with the loss of
POMC expression in the intermediate lobe of Tpit null mice
(Pulichino et al., 2003b).
Lhx3 is necessary for normal expression of TPIT and
NEUROD1 and for survival of pre-corticotrope cells
The importance of Tpit and Neurod1 for corticotrope
development is well established (Lamolet et al., 2001, 2004;
Poulin et al., 1997; Reynaud et al., 2004). Tpit is required for
late corticotrope differentiation and maintenance, and/or
proliferation of these cells, but is not required for initiation of
differentiation (Pulichino et al., 2003a,b). Corticotrope differ-
entiation is delayed in NeuroD1 null mice, but appears to be
fully recovered by e16.5 (Lamolet et al., 2004). Pituitary
development inTpit/Neurod1 double null mice is similar to that
of single Tpit null mice (Pulichino et al., 2004). From these
studies, it seems that there are other factors involved in
stimulating the initial steps of corticotrope differentiation.
The paucity of POMC expressing cells in Lhx3 mutants is
preceded by reduced expression of TPIT and NEUROD1.
NEUROD1 may have a role in the pituitary similar to that of
NEUROM in motor neurons. NEUROM synergizes with ISL1
and LHX3 to develop motor neurons in the embryonic spinalcord (Lee and Pfaff, 2003). NEUROD1 may act synergistically
with ISL1 and LHX3 to promote corticotrope differentiation.
Differentiation of all but the earliest POMC expressing cells is
dependent on Lhx3. We hypothesize that differentiation is
initiated at e14.5 with the expression of TPIT and NEUROD1,
and without LHX3, differentiation is arrested and the cells die.
In Lhx3mutants, apoptosing cells are present in the region of
Rathke's pouch where the prospective anterior lobe should be
forming at e12.5. It appears that these cells are migrating
appropriately, but dying. Are these cells dying due to an inability
to differentiate? We have shown that a subset of pre-corticotrope
cells appear to localize to regions of cell death, resulting in a
paucity of terminally differentiated corticotrope cells.
Lhx3 mutant pituitaries express SF1, but do not contain fully
differentiated gonadotropes
Failure of Lhb to be expressed in Lhx3 null mice is not
attributable to a lack of GnRH input, as initial expression of
Lhb is not dependent on GnRH stimulation (Pask et al.,
2005). In fact, several groups have shown that hypothalamic
stimulation is not necessary for hormone cell differentiation
(Lin et al., 1993; Mason et al., 1986; Muglia et al., 1995; Pask
et al., 2005; Shibusawa et al., 2000; Timpl et al., 1998). The
roles of the hypothalamic releasing hormones are typically
evident after birth when they begin to regulate the secretion of
hormones from different pituitary cells and stimulate expan-
sion of differentiated cell populations. They appear to play
little or no role in orchestrating the differentiation of pituitary
hormone producing cells. Thus, we investigated the gonado-
trope differentiation defect in Lhx3 mice by studying the
expression of transcription factors associated with gonadotrope
expression.
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differentiation based on its expression at e14.5 and its important
role in Gnrhr, Lhb, and Fshb expression in the following days
of gestation (Duval et al., 1997; Jacobs et al., 2003; Lee et al.,
1996). However, it is possible that gonadotropes initiate the
differentiation process sooner, at e12.5, with the expression of
Foxl2. This occurs concomitant with the initial expression of
Cga, the α-subunit common to the gonadotropins and
thyrotropin. Also, activated FOXL2 is sufficient to stimulate
Cga expression. Lhx3 mutants express neither FOXL2 nor
Cga (Ellsworth et al., 2006; Sheng et al., 1996).
Based on the absence of Lhb transcripts in Lhx3 mutant
mice, we expected to find a deficiency in SF1 because SF1 is
essential for Lhb expression. The poor expression of POMC at
e14.5 suggests that Lhx3 mutant pituitaries are failing by this
time. However, SF1 is expressed in mutants at e14.5, indicating
that while gonadotropes are not fully differentiated, this aspect
of their specification is initiated despite the transient loss of
ISL1 and complete failure to express FOXL2. Clearly Lhx3 is
not required for activation of SF1 expression, and SF1 is not
sufficient for Lhb expression. Consistent with this, mutation of
the homeobox transcription factor, Prop1, results in ectopic,
dorsal expression of SF1, but these cells do not express the
glycoprotein hormone α-subunit, suggesting that they do not
differentiate into hormone producing cells (Raetzman et al.,
2002).
ISL1 is initially expressed throughout Rathke's pouch, but
its expression is restricted to the prospective anterior lobe by
e12.5. It is expressed in gonadotrope cells later in pituitary
development (Ericson et al., 1998; Liu et al., 2005a,b). ISL1 is
not expressed in Lhx3 mutants at e12.5, but is expressed before
and after this time point. Lhx3 Cre-insertion mutants lack Isl1
expression at e12.5, but other time points were not examined
(Zhao et al., 2006). The transient loss of ISL1 expression
shows that Lhx3 is necessary for maintenance of ISL1
expression during a critical time period, when ISL1 expression
is being restricted to the prospective anterior lobe. This is
similar to the requirement of Lhx3 for maintenance of Hesx1
expression (Sheng et al., 1996). However, the expression of
Isl1 later in Lhx3 mutant mice suggests that other factors are
responsible for Isl1 expression at later stages. Isl1 and Lhx3
expression overlaps early in pituitary development (e9.5–
e10.5) but becomes mutually exclusive after that (Ericson et
al., 1998). In motor neurons, expression of Isl1 and Lhx3
overlaps. These factors synergize with each other to determine
the fate of motor neurons in the developing spinal cord,
contributing to what is referred to as the “LIM code” for
determination of motor neuron differentiation (Gill, 2003;
Shirasaki et al., 2006).
In light of our findings, we suggest that Lhx3 is required for
Isl1 expression only transiently at e12.5. While Lhx3 appears to
be required for differentiation of a common precursor for the
Pit1 lineage, the presence of SF1 suggests that this aspect of
pre-gonadotrope differentiation is independent of Lhx3. Inter-
estingly, earlier (FOXL2 and αGSU expression) and later (LHβ
expression) aspects of gonadotrope differentiation do require
Lhx3.Lhx3 is necessary for correct dorsal–ventral patterning in the
pituitary
Initial patterning of the pituitary is established by signaling
pathways such as SHH and BMP2 that emanate from the ventral
region, and dorsal BMP4 and FGF8 signals that are modulated
by the BMP inhibitor, noggin (Davis and Camper, 2007). These
antagonistic signaling gradients lead to the spatially and
temporally restricted expression patterning of pituitary tran-
scription factors (Ericson et al., 1998; Reynaud et al., 2004;
Treier et al., 2001). In turn, these localized and overlapping
“zones” of transcription factor expression govern the patterning
and positional determination of the five pituitary cell types.
Explant studies show that shifting the patterns of ISL1 and
LHX3 expression by altering signaling, results in altered
proportions of differentiated cells along the dorsal/ventral axis
(Ericson et al., 1998).
LHX3 and LHX4 are structurally related and have redundant
functions in the pituitary (Sheng et al., 1997). LHX4 is required
for timely activation of Lhx3, but this is not simply a linear
pathway with overlapping functions. ISL1 is not detected in
Lhx3 null pituitaries at e12.5, but loss of Lhx4 results in an
expanded pattern of ISL1 expression (Raetzman et al., 2002)
(Fig. 6A).
We report a new aspect of the pituitary phenotype of Lhx3
null pituitaries, namely the dorsalization of what appears to be
progenitors of the normally ventral cell types. Lhx3 is normally
more highly expressed dorsally, and may suppress expression of
genes typically excluded from this area. It may do this directly,
or in conjunction with TPIT. In the absence of Lhx3, there is
very little sustained TPIT expression, and ventrally restricted
factors (SF1 and ISL1) are expressed ectopically in the dorsal
area. Tpit deficiency is expected to trigger cell fate changes that
include ectopic SF1 expression and activation of Cga and Lhb
(Pulichino et al., 2003a,b). However, Lhx3 mutants do not
express either αGSU or LHβ in normal or ectopic sites (Sheng
et al., 1996). Thus, the loss of TPIT in Lhx3 mutants may
contribute to dorsal activation of SF1 expression; however,
clearly additional factors are required to complete the gonado-
trope differentiation process (Fig. 6B). We hypothesize that
LHX3 plays an antagonistic role confining ventral factors to the
appropriate region through enhancement of TPIT expression
(Fig. 6B).
NOTCH signaling is critical for boundary formation and
regulation of the transition from proliferation to cellular
differentiation in many organ systems (Cho and Choi, 1998;
Dominguez and de Celis, 1998; Fanto and Mlodzik, 1999;
Micchelli and Blair, 1999; Mucchielli and Mitsiadis, 2000;
Raetzman et al., 2006). Several studies have implicated NOTCH
signaling as an important regulator of pituitary gland develop-
ment (Kita et al., 2007; Raetzman et al., 2007; Zhu et al., 2006).
Ectopic expression of activated NOTCH2 is sufficient to delay
differentiation of gonadotrope cells (Raetzman et al., 2006). In
addition, Prop1 mutants fail to express NOTCH2 and exhibit
failure of the entire Pit1 lineage (Raetzman et al., 2004). The
lack of NOTCH2 expression in Lhx3 mutants is consistent with
their failure to activate Pit1 expression. Based on this evidence,
Fig. 6. Lhx3 plays an important role in pituitary development. (A) While Lhx4 deficiency results in dorsal spreading of ISL1 at e12.5 (Raetzman et al., 2002), absence
of Lhx3 causes a transient loss of ISL1 expression at this age, demonstrating that Lhx3 and Lhx4 can have very different effects on gene expression in the pituitary. (B)
Tpit is required to suppress SF1 expression in the dorsal aspect of the pituitary gland. Without Tpit, SF1 is expressed in the intermediate lobe and complete
gonadotrope differentiation occurs as evidenced by αGSU and LHβ expression. Prop1df/df mutants have no obvious abnormalities in TPIT expression, but SF1 is
expressed ectopically in the dorsal aspect of the gland. SF1 is not, however, sufficient to complete the gonadotrope differentiation program in this case. NOTCH2
expression fails completely in Prop1df/df mutants. Lhx3 nulls lack both TPIT and NOTCH2 and exhibit a loss of gonadotrope differentiation that appears to correlate
with the lack of NOTCH2 expression. Ectopic expression of gonadotrope marker, SF1, occurs, but no gonadotropin expression ensues. This suggests that Lhx3 is
required to complete the gonadotrope differentiation program. (C) Lhx3 is important for cell survival of pre-corticotropes. Lhx3 deficiency results in a severe reduction
in pre-corticotropes as evidenced by reduced expression of NEUROD1 and TPIT. A reduction in differentiated corticotropes, as well as melanotropes, is demonstrated
by a reduction in POMC expression. Gonadotropes are able to proceed with aspects of their differentiation process without Lhx3 as indicated by the presence of SF1,
but are unable to express many markers of differentiation (FOXL2, LHβ, αGSU) (Ellsworth et al., 2006; Sheng et al., 1996). Lhx3 is required for NOTCH2
expression, which may be important for appropriate dorsal–ventral cell specification and/or suppression of precocious differentiation of dorsal cell types. Finally, Lhx3
is required for expression of Pit1 and the Pit1 lineage (thyrotropes, somatotropes, lactotropes) (Sheng et al., 1996). Together, these studies demonstrate that Lhx3 is a
critical factor in the complex process of pituitary patterning and cell specification. Transcription factors are shown in green and hormones and other genes are shown in
blue. Proteins studied using immunohistochemistry are represented in all capital letters and genes studied using in situ hybridization are represented in italics.
127B.S. Ellsworth et al. / Developmental Biology 313 (2008) 118–129we anticipate that failed NOTCH signaling in Lhx3 mutants
could contribute to ectopic gene expression in dorsal cell types
and failure to activate Pit1.
In conclusion, we have delineated the roles of Lhx3 in
differentiation of anterior and intermediate lobe cell types (Fig.6C). It is intriguing that it is necessary for survival of some, but
not all corticotropes and for maintenance of the corticotrope and
melanotrope lineage transcription factor TPIT. In addition,
Lhx3 is necessary for activation of some of the initial and final
steps of the gonadotrope differentiation program, but not for
128 B.S. Ellsworth et al. / Developmental Biology 313 (2008) 118–129expression of the lineage-specific factor, SF1. The data we have
presented in this paper add to what is known about the role of
Lhx3 in pituitary development and deepen the breadth of
knowledge about how pituitary transcription factors work
together to regulate pituitary development and function
(Pitx1,2, Lhx3,4, Pit1, Sf1, Isl1, Tle3, Tpit, NeuroD1). While
it is tempting to think about differentiation as a linear process,
the picture that emerges from these studies is a complex
interplay of factors that have roles in initiation and maintenance
of gene expression.
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